Sunshine Biopharma (SBFM) Research & Development (2011 - 2026)
Sunshine Biopharma (SBFM) reported Research & Development of $31724.0 for Q1 2026, down 85.26% on a YoY basis from $215277.0 in Q1 2025, and down 56.84% quarter-over-quarter from $73501.0 in Q4 2025.
Sunshine Biopharma (SBFM) Research & Development (2011 - 2026) Analysis & Trends
Sunshine Biopharma has reported Research & Development for 14 years, with the latest figure at $31724.0 in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 85.26% year-over-year to $31724.0; the trailing twelve-month figure through Mar 2026 stood at $420755.0 (down 54.62% YoY), and the FY2025 full-year result was $604308.0, down 35.29% from the prior year.
- Research & Development for Q1 2026 stood at $31724.0, down from $73501.0 in the prior quarter.
- The five-year high for Research & Development was $816328.0 in Q4 2023, with the low at $31724.0 in Q1 2026.
- Historically, Research & Development has averaged $249271.9 across 5 years, with a median of $215277.0 in 2025.
- Annual changes were most pronounced in 2023 — Research & Development soared 1854.67% — and 2026, when it slumped 85.26%.
- Sunshine Biopharma's Research & Development stood at $41763.0 in 2022, then soared by 1854.67% to $816328.0 in 2023, then slumped by 81.71% to $149272.0 in 2024, then sank by 50.76% to $73501.0 in 2025, then tumbled by 56.84% to $31724.0 in 2026.
- The last three Research & Development figures came in at $31724.0 (Q1 2026), $73501.0 (Q4 2025), and $119298.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 39.38 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 46.94 Mn |
| 10 | Sunshine Biopharma | 11.70 Mn | 4.79 Mn | 2.18 Mn | 31,724.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,724.00 |
| Dec 31, 2025 | 73,501.00 |
| Sep 30, 2025 | 119,298.00 |
| Jun 30, 2025 | 196,232.00 |
| Mar 31, 2025 | 215,277.00 |
| Dec 31, 2024 | 149,272.00 |
| Sep 30, 2024 | 126,362.00 |
| Jun 30, 2024 | 436,235.00 |
| Mar 31, 2024 | 222,033.00 |
| Dec 31, 2023 | 816,328.00 |
| Sep 30, 2023 | 238,012.00 |
| Jun 30, 2023 | 368,565.00 |
| Mar 31, 2023 | 432,925.00 |
| Dec 31, 2022 | 41,763.00 |
| Sep 30, 2022 | 362,500.00 |
| Jun 30, 2022 | 45,943.00 |
| Mar 31, 2022 | 361,652.00 |
| Dec 31, 2021 | 91,198.00 |
| Sep 30, 2021 | 222,465.00 |
| Jun 30, 2021 | 191,760.00 |